Bvf Inc Galapagos Nv Transaction History

Bvf Inc

$3.34 Billion
Q1 2024

A detailed history of Bvf Inc transactions in Galapagos Nv stock. As of the latest transaction made, Bvf Inc holds 1,863,809 shares of GLPG stock, worth $46.2 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares

1,863,809

Previous 1,915,109 2.68%

Holding current value

$46.2 Million

Previous $77.8 Million 22.91%

% of portfolio

1.8%

Previous 2.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$32.2 - $42.44 $1.65 Million - $2.18 Million	-51,300 Reduced 2.68%	1,863,809 $60 Million
Q3 2023 Nov 14, 2023	SELL	$34.17 - $42.98 $8.54 Million - $10.7 Million	-250,000 Reduced 11.55%	1,915,109 $66.2 Million
Q1 2023 May 15, 2023	BUY	$36.5 - $48.0 $75.4 Million - $99.1 Million	2,065,109 Added 2065.11%	2,165,109 $83.7 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $3.74 Million - $4.65 Million	100,000 New	100,000 $4.44 Million
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $54.7 Million - $74.9 Million	-1,046,283 Closed	0 $0

Q1 2022 May 16, 2022	SELL	$51.32 - $68.5 $5.65 Million - $7.54 Million	-110,110 Reduced 9.52%	1,046,283 $64.9 Million
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $1.72 Million - $2.09 Million	36,660 Added 3.27%	1,156,393 $63.8 Million
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $58.4 Million - $78.6 Million	1,119,733 New	1,119,733 $58.9 Million
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $1.42 Million - $1.77 Million	-7,674 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $1.1 Million - $2.1 Million	7,674 New	7,674 $1.5 Million
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $44.6 Million - $65.8 Million	-305,076 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$130.44 - $187.64 $39.8 Million - $57.2 Million	305,076 New	305,076 $46.6 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

16.5M

Call Options Held

77.1K

Put Options Held

57.2K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.63B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account